Is ADC a rising star in solid tumor? An umbrella review of systematic reviews and meta-analyses
Abstract Background Antibody-drug conjugates (ADCs) combine the specificity of monoclonal antibodies with the potency of highly cytotoxic drugs and are known as panaceas, completely changing the treatment paradigm for solid tumors. Compared with other anti-cancer drugs, do they have better efficacy...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
BMC
2025-02-01
|
| سلاسل: | BMC Cancer |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1186/s12885-025-13726-8 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|